SCHEMBL8304542

SCHEMBL8304542

CC(=NOCCO)c1ccc(-c2ccccc2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.54
LDHA P00338 1/20 0.48
BAZ2B Q9UIF8 1/20 0.46
LMNA P02545 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGDS O60760 1/20 0.42
CYP3A4 P08684 1/20 0.40
PPARA Q07869 5/20 0.38
ALDH1A1 P00352 1/20 0.37
RECQL P46063 1/20 0.37
MET P08581 1/20 0.36
GAA P10253 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304541 1.00 PPARG (0.54) PPARGLDHABAZ2BLMNAMAPK1
SCHEMBL5610177 0.81 CYP1A2 (0.47) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL5610182 0.81 CYP1A2 (0.47) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL5610798 0.81 LMNA (0.56) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL5610797 0.81 LMNA (0.56) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL4476864 0.77 LMNA (0.69) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL4476867 0.77 LMNA (0.69) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL8310072 0.77 PPARG (0.46) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL8310069 0.77 PPARG (0.46) PPARGLMNAMAPK1HTTL3MBTL1
SCHEMBL8686143 0.77 LDHA (0.49) PPARGLDHABAZ2BLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0918769-A1 SUBSTITUTED PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTI-BACTERIAL AGENTS AstraZeneca AB (SE) 1999-06-02 EP disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
WO-1998001446-A1 SUBSTITUTED PIPERAZINYL-PHENYL-OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTI-BACTERIAL AGENTS ZENECA LIMITED (GB) 1998-01-15 WO disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed